Hsbc Holdings PLC Sells 50,085 Shares of The Cooper Companies, Inc. $COO

Hsbc Holdings PLC cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 12.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 359,291 shares of the medical device company’s stock after selling 50,085 shares during the quarter. Hsbc Holdings PLC’s holdings in Cooper Companies were worth $29,459,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Root Financial Partners LLC lifted its holdings in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares during the period. Bell Investment Advisors Inc grew its holdings in Cooper Companies by 106.3% during the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after acquiring an additional 219 shares during the period. CYBER HORNET ETFs LLC acquired a new stake in Cooper Companies during the 2nd quarter worth about $36,000. True Wealth Design LLC raised its position in shares of Cooper Companies by 484.8% in the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after acquiring an additional 383 shares in the last quarter. Finally, Cromwell Holdings LLC raised its position in shares of Cooper Companies by 128.8% in the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after acquiring an additional 273 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $72.61 on Tuesday. The firm’s 50-day moving average price is $64.66 and its 200-day moving average price is $73.26. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The firm has a market capitalization of $14.16 billion, a P/E ratio of 61.53, a P/E/G ratio of 1.94 and a beta of 0.84. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business’s revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research note on Wednesday, May 27th. Citigroup reiterated a “neutral” rating and issued a $69.00 target price (down from $80.00) on shares of Cooper Companies in a report on Thursday, May 28th. Needham & Company LLC lowered their target price on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday, June 5th. Stifel Nicolaus dropped their price target on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Finally, Robert W. Baird cut their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $81.31.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.